Committee Composition

  Audit Nominating and Governance Compensation & Mgmt Development Mergers and Acquisitions
Rolf A. Classon Chairman of the Board Independent Director   Committee Chair for Nominating and Governance Committee   Committee Chair for Mergers and Acquisitions Committee
John J. Greisch        
William G. Dempsey Independent Director Member of Audit Committee      
Stacy Enxing Seng Independent Director     Member of Compensation & Mgmt Development Committee  
Mary Garrett Member of Audit Committee      
James R. Giertz Independent Director Member of Audit Committee      
Charles E. Golden Independent Director Committee Chair for Audit Committee Member of Nominating and Governance Committee   Member of Mergers and Acquisitions Committee
William H. (Hank) Kucheman Independent Director     Member of Compensation & Mgmt Development Committee Member of Mergers and Acquisitions Committee
William Kucheman Retired CEO of Boston Scientific Corporation

Mr. Kucheman has served as a director of Hill-Rom since 2013. He previously served as interim Chief Executive Officer for Boston Scientific Corp. Before being named interim CEO in October 2011, he was Executive Vice President and President of the Cardiology, Rhythm and Vascular (CRV) Group of Boston Scientific. He joined the Company in 1995 as a result of Boston Scientific’s acquisition of SCIMED Life Systems, Inc. becoming Senior Vice President of Marketing. In this role, Mr. Kucheman was responsible for global marketing. He has served on several industry boards, including the board of directors of the Global Health Exchange and on the boards of several non-public companies.

Mr. Kucheman’s executive experience with invasive medical devices, including FDA regulation, commercialization process, government reimbursement, and clinical marketing, makes him highly qualified to serve on the Board.


Ronald A. Malone Independent Director   Member of Nominating and Governance Committee Committee Chair for Compensation & Mgmt Development Committee Member of Mergers and Acquisitions Committee
Nancy M. Schlichting     Member of Compensation & Mgmt Development Committee  
Chair of the Board = Chair of the Board Committee Chair = Chair Committee Member = Member Independent Director = Independent Director


Meetings and Committees of the Board of Directors

It is the general policy of the Company that all significant decisions be considered by the Board as a whole. As a consequence, the committee structure of the Board is limited to those committees considered to be basic to, or required for, the operation of a publicly owned company. Currently these committees are the Compensation and Management Development Committee, Audit Committee and Nominating/Corporate Governance Committee, each of which has a written charter adopted by the Board of Directors. The Nominating/Corporate Governance Committee recommends the members and chairs of these committees to the Board. The Audit Committee, Compensation and Management Development Committee and Nominating/Corporate Governance Committee are made up of only independent directors. The current charter for each of the Board's standing committees is available on this website and is available in print from this website or to any shareholder who requests it through the Company's Investor Relations office.

During the fiscal year ended September 30, 2009, the Board of Directors of the Company held seven meetings. During this period, no member of the Board of Directors attended fewer than 75% of the aggregate of the number of meetings of the full Board of Directors and the number of meetings of the committees on which he or she served.




PDF Download PDF   55.0 KB   Add to Briefcase

PDF Download PDF  225.9 KB   Add to Briefcase

PDF Download PDF  142.3 KB   Add to Briefcase